retatrutide triple agonist obesity phase 2 trial 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in 3 New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Cagrilintide vs Retatrutide Compared |

Not exactly a side effect anyone calls the clinic about

The selenium group showed no change in TSH levels

Potential mechanisms being explored include: Reduction in pro-inflammatory cytokines Antioxidant enzyme support Reduction in oxidative tissue damage Improved tissue healing environment This is one reason GHK-Cu has become so popular in regenerative and longevity medicine

Benefits: Enhanced fat burning and lean mass gain Improved recovery and sleep Balanced energy levels 3X Blend (Tesamorelin + MGF + Ipamorelin) Purpose: Combines anabolic and restorative peptides for advanced performance and tissue repair

The Phase 2 obesity results have been published, and the Phase 3 programme known as TRIUMPH is ongoing and has not reported final results